Auxogyn
Auxogyn, now operating as Progyny, provides comprehensive women's health and family building benefits for employers and health plans. The platform delivers end-to-end coverage spanning fertility and family building, pregnancy and postpartum care, parenting and child well-being, and menopause support. Its data-driven model combines high-touch personalized care through dedicated Progyny Care Advocates with a digital…
Funding snapshot
About
Auxogyn, now operating as Progyny, provides comprehensive women's health and family building benefits for employers and health plans. The platform delivers end-to-end coverage spanning fertility and family building, pregnancy and postpartum care, parenting and child well-being, and menopause support. Its data-driven model combines high-touch personalized care through dedicated Progyny Care Advocates with a digital experience platform, delivering superior clinical outcomes that consistently exceed national averages. The company maintains the largest actively managed women's health provider network with NCQA accreditation in credentialing, supporting 600+ companies across 45+ industries in 120+ countries. Its Progyny Global solution offers locally compliant benefits in 30+ languages, while Progyny Select brings fertility and family building coverage to small and mid-sized employers through a fully insured supplemental plan. Founded in 2008 and headquartered in Menlo Park, United States, the company has raised approximately $78.4M in Series C funding from investors including SR One, TPG, M Ventures, and Kleiner Perkins.
Business model
Women Health > In Vitro Diagnostic Tests > Embryo Viability
Founders & team highlights
Serial Founder
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.